| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025769951 |
| P356 | DOI | 10.1186/S13014-016-0626-6 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13014-016-0626-6 |
| P932 | PMC publication ID | 4818859 |
| P698 | PubMed publication ID | 27039175 |
| P2093 | author name string | Henrik Antti | |
| A Tommy Bergenheim | |||
| Carl Wibom | |||
| Lina Mörén | |||
| Mikael Johansson | |||
| Per Bergström | |||
| P2860 | cites work | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 |
| The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
| High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses | Q31002172 | ||
| Monitoring of gliomas in vivo by diffusion MRI and (1)H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids | Q33384488 | ||
| Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling | Q33781082 | ||
| Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI. | Q33888366 | ||
| Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy. | Q33907367 | ||
| Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects | Q33933312 | ||
| Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy | Q34498046 | ||
| Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. | Q34498073 | ||
| Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma | Q35760631 | ||
| Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis | Q36497282 | ||
| Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information | Q38961858 | ||
| Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells | Q40110136 | ||
| Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas | Q40525983 | ||
| Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study | Q43123788 | ||
| Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy. | Q43269542 | ||
| ADC texture--an imaging biomarker for high-grade glioma? | Q43546624 | ||
| Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas | Q43634719 | ||
| Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis | Q44352421 | ||
| Modulation of neuronal migration by NMDA receptors | Q48305180 | ||
| Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. | Q48908809 | ||
| A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. | Q52001513 | ||
| Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. | Q53495225 | ||
| O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma. | Q55463048 | ||
| Correlation of myo-inositol levels and grading of cerebral astrocytomas. | Q55475043 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Principal component analysis | Q56763826 | ||
| Radiation-induced hypopituitarism | Q87013555 | ||
| P304 | page(s) | 51 | |
| P577 | publication date | 2016-04-02 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas | |
| P478 | volume | 11 |
| Q48211090 | A Serum Small Molecule Biosignature of Radiation Exposure from Total Body Irradiated Patients. |
| Q102072973 | Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points |
| Q59799685 | Metabolite normalization with local radiotherapy following breast tumor resection |
| Q38689857 | Metabolomics applications in precision medicine: An oncological perspective |
| Q36955193 | Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia |
| Q89510879 | Targeting Glutamine Addiction in Gliomas |
| Q64949815 | Temporal Effects on Radiation Responses in Nonhuman Primates: Identification of Biofluid Small Molecule Signatures by Gas Chromatography⁻Mass Spectrometry Metabolomics. |
Search more.